AIM ImmunoTech (AIM) Q1 2024 Annual Earnings
AIM·Reported May 16, 2024·Before market open
AIM ImmunoTech reported Q1 2024 revenue of $40.0K. Diluted EPS came in at $-12.00, missed the $-0.11 consensus by $11.89.
Revenue
$40.0K
Diluted EPS
$-12.00missed by $11.89
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about AIM ImmunoTech's Q1 2024 earnings report.
AIM ImmunoTech (AIM) reported Q1 2024 earnings on May 16, 2024 before market open.
AIM ImmunoTech reported revenue of $40.0K and diluted EPS of $-12.00 for Q1 2024.
EPS missed the consensus estimate of $-0.11 by $11.89.
You can read the 10-K periodic report (0001493152-24-012058) directly on SEC EDGAR. The filing index links above go to sec.gov.